Insulet Corp
NASDAQ:PODD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
161.02
275.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Insulet Corp
Wall Street
Price Targets
PODD Price Targets Summary
Insulet Corp
According to Wall Street analysts, the average 1-year price target for
PODD
is 293.66 USD
with a low forecast of 236.34 USD and a high forecast of 357 USD.
PODD Last Price Targets
Insulet Corp
The latest public price target was made on Nov 8, 2024 by
Marie Thibault
from
BTIG
,
who expects
PODD
stock to
rise by 3%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Marie Thibault
BTIG
|
270
USD
Upside 3% |
1 month ago
Nov 8, 2024
|
Insulet Corporation (PODD) PT Raised to $270 at BTIG
StreetInsider
|
Lee Hambright
Bernstein
|
300
USD
Upside 14% |
1 month ago
Nov 5, 2024
|
Bernstein SocGen Group Starts Insulet Corporation (PODD) at Outperform
StreetInsider
|
Jayson Bedford
Raymond James
|
260
USD
Downside 1% |
2 months ago
Oct 14, 2024
|
Insulet price target raised to $260 from $213 at Raymond James
TheFly
|
Matt O'Brien
Piper Sandler
|
285
USD
Upside 8% |
3 months ago
Sep 17, 2024
|
Insulet price target raised to $285 from $230 at Piper Sandler
TheFly
|
|
Matt O'Brien
Piper Sandler
|
230
USD
Downside 13% |
3 months ago
Aug 27, 2024
|
Piper Sandler Reiterates Overweight Rating on Insulet Corporation (PODD)
StreetInsider
|
Steven Lichtman
Oppenheimer
|
233
USD
Downside 11% |
3 months ago
Aug 27, 2024
|
Oppenheimer Reiterates Outperform Rating on Insulet Corporation (PODD)
StreetInsider
|
Matthew Taylor
Jefferies
|
260
USD
Downside 1% |
3 months ago
Aug 27, 2024
|
Jefferies Reiterates Buy Rating on Insulet Corporation (PODD)
StreetInsider
|
|
Marie Thibault
BTIG
|
250
USD
Downside 5% |
4 months ago
Aug 9, 2024
|
Insulet price target lowered to $250 from $270 at BTIG
TheFly
|
Matt Miksic
Barclays
|
200
USD
Downside 24% |
7 months ago
May 13, 2024
|
Insulet price target lowered to $200 from $213 at Barclays
TheFly
|
Mike Polark
Wolfe Research
|
200
USD
Downside 24% |
7 months ago
May 7, 2024
|
Insulet upgraded to Outperform from Peer Perform at Wolfe Research
TheFly
|
Kyle Rose
Canaccord Genuity
|
226
USD
Downside 14% |
9 months ago
Mar 21, 2024
|
Canaccord Genuity Likes Insulet Corporation (PODD) Management Appointment
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PODD's stock price target?
Price Target
293.66
USD
According to Wall Street analysts, the average 1-year price target for
PODD
is 293.66 USD
with a low forecast of 236.34 USD and a high forecast of 357 USD.
What is Insulet Corp's Revenue forecast?
Projected CAGR
18%
For the last 8 years the
compound annual growth rate for
Insulet Corp's revenue is
26%.
The projected
CAGR
for the next 4 years is
18%.
What is Insulet Corp's Operating Income forecast?
Projected CAGR
28%
The
compound annual growth rate
of Insulet Corp's operating income for the next 4 years is
28%.
What is Insulet Corp's Net Income forecast?
Projected CAGR
19%
The
compound annual growth rate
of Insulet Corp's net income for the next 4 years is
19%.
You don't have any saved screeners yet
